Triple bioluminescence imaging for in vivo monitoring of cellular processes

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages

  Maguire, Casey A ^a,b   Bovenberg, M Sarah ^a,b,c   Crommentuijn, Matheus H W ^a,b,d   Niers, Johanna M ^a,b,d   Kerami, Mariam ^a,b,d   Teng, Jian ^a,b   Sena Esteves, Miguel ^e   Badr, Christian E ^a,b   Tannous, Bakhos A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

bioluminescence imaging; firefly luciferase; Gaussia luciferase; Vargula luciferase

Indexed keywords

DEATH RECEPTOR; FIREFLY LUCIFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERIN; PARVOVIRUS VECTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; BIOLUMINESCENCE; BRAIN TUMOR; CELL ACTIVITY; CODON; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GLIOMA CELL; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MAMMALIAN GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRIPLE BIOLUMINESCENCE IMAGING;

EID: 84879915815     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.25     Document Type: Article

References (38)

1. Badr, CE, Hewett, JW, Breakefield, XO and Tannous, BA (2007). A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS ONE 2: e571.
2. Contag, CH, Contag, PR, Mullins, JI, Spilman, SD, Stevenson, DK and Benaron, DA (1995). Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18: 593-603. (Pubitemid 26008843)
3. Rabinovich, BA, Ye, Y, Etto, T, Chen, JQ, Levitsky, HI, Overwijk, WW et al. (2008). Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci USA 105: 14342-14346.
4. Tannous, BA, Kim, DE, Fernandez, JL, Weissleder, R and Breakefield, XO (2005). Codonoptimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11: 435-443. (Pubitemid 40277320)
5. Loening, AM, Wu, AM and Gambhir, SS (2007). Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Methods 4: 641-643. (Pubitemid 47202475)
6. Branchini, BR, Southworth, TL, Khattak, NF, Michelini, E and Roda, A (2005). Red-and green-emitting firefly luciferase mutants for bioluminescent reporter applications. Anal Biochem 345: 140-148. (Pubitemid 41558205)
7. Branchini, BR, Ablamsky, DM, Murtiashaw, MH, Uzasci, L, Fraga, H and Southworth, TL (2007). Thermostable red and green light-producing firefly luciferase mutants for bioluminescent reporter applications. Anal Biochem 361: 253-262. (Pubitemid 46135385)
8. Kim, SB, Suzuki, H, Sato, M and Tao, H (2011). Superluminescent variants of marine luciferases for bioassays. Anal Chem 83: 8732-8740.
9. Loening, AM, Fenn, TD, Wu, AM and Gambhir, SS (2006). Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel 19: 391-400. (Pubitemid 44306057)
10. Vilalta, M, Jorgensen, C, Dégano, IR, Chernajovsky, Y, Gould, D, Noël, D et al. (2009). Dual luciferase labelling for non-invasive bioluminescence imaging of mesenchymal stromal cell chondrogenic differentiation in demineralized bone matrix scaffolds. Biomaterials 30: 4986-4995.
11. Wendt, MK, Molter, J, Flask, CA and Schiemann, WP (2011). In vivo dual substrate bioluminescent imaging. J Vis Exp 56: 3245.
12. Bhaumik, S, Lewis, XZ and Gambhir, SS (2004). Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice. J Biomed Opt 9: 578-586.
13. Thompson, EM, Nagata, S and Tsuji, FI (1989). Cloning and expression of cDNA for the luciferase from the marine ostracod Vargula hilgendorfii. Proc Natl Acad Sci USA 86: 6567-6571. (Pubitemid 19236318)
14. Wurdinger, T, Badr, C, Pike, L, de Kleine, R, Weissleder, R, Breakefield, XO et al. (2008). A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 5: 171-173. (Pubitemid 351181745)
15. Wu, X, He, Y, Falo, LD Jr, Hui, KM and Huang, L (2001). Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. Mol Ther 3: 368-374. (Pubitemid 32514653)
16. Badr, CE, Niers, JM, Tjon-Kon-Fat, LA, Noske, DP, Wurdinger, T and Tannous, BA (2009). Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. Mol Imaging 8: 278-290.
17. Chaudhary, PM, Eby, M, Jasmin, A, Bookwalter, A, Murray, J and Hood, L (1997). Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7: 821-830. (Pubitemid 28064895)
18. Inouye, S, Ohmiya, Y, Toya, Y and Tsuji, FI (1992). Imaging of luciferase secretion from transformed Chinese hamster ovary cells. Proc Natl Acad Sci USA 89: 9584-9587.
19. Thompson, EM, Nagata, S and Tsuji, FI (1990). Vargula hilgendorfii luciferase: a secreted reporter enzyme for monitoring gene expression in mammalian cells. Gene 96: 257-262.
20. Thompson, EM, Adenot, P, Tsuji, FI and Renard, JP (1995). Real time imaging of transcriptional activity in live mouse preimplantation embryos using a secreted luciferase. Proc Natl Acad Sci USA 92: 1317-1321.
21. Tanahashi, Y, Ohmiya, Y, Honma, S, Katsuno, Y, Ohta, H, Nakamura, H et al. (2001). Continuous measurement of targeted promoter activity by a secreted bioluminescence reporter, Vargula hilgendorfii luciferase. Anal Biochem 289: 260-266. (Pubitemid 32173674)
22. Ura, S, Ueda, H, Kazami, J, Kawano, G and Nagamune, T (2001). Single cell reporter assay using cell surface displayed Vargula luciferase. J Biosci Bioeng 92: 575-579. (Pubitemid 34107178)
23. Santos, EB, Yeh, R, Lee, J, Nikhamin, Y, Punzalan, B, Punzalan, B et al. (2009). Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase. Nat Med 15: 338-344.
24. Niers, JM, Chen, JW, Lewandrowski, G, Kerami, M, Garanger, E, Wojtkiewicz, G et al. (2012). Single reporter for targeted multimodal in vivo imaging. J Am Chem Soc 134: 5149-5156.
25. Weissleder, R and Pittet, MJ (2008). Imaging in the era of molecular oncology. Nature 452: 580-589. (Pubitemid 351483372)
26. Gammon, ST, Leevy, WM, Gross, S, Gokel, GW and Piwnica-Worms, D (2006). Spectral unmixing of multicolored bioluminescence emitted from heterogeneous biological sources. Anal Chem 78: 1520-1527. (Pubitemid 43346289)
27. Ntziachristos, V (2006). Fluorescence molecular imaging. Annu Rev Biomed Eng 8: 1-33. (Pubitemid 44314811)
28. Badr, CE and Tannous, BA (2011). Bioluminescence imaging: progress and applications. Trends Biotechnol 29: 624-633.
29. Ding, L, Yuan, C, Wei, F, Wang, G, Zhang, J, Bellail, AC et al. (2011). Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP. Cancer Invest 29: 511-520.
30. Chamuleau, ME, Ossenkoppele, GJ, van Rhenen, A, van Dreunen, L, Jirka, SM, Zevenbergen, A et al. (2011). High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2. Leuk Res 35: 741-749.
31. Panner, A, James, CD, Berger, MS and Pieper, RO (2005). mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 25: 8809-8823. (Pubitemid 41429073)
32. Zhang, L and Fang, B (2005). Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 12: 228-237. (Pubitemid 40315182)
33. Ibrahim, SM, Ringel, J, Schmidt, C, Ringel, B, Müller, P, Koczan, D et al. (2001). Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Pancreas 23: 72-79. (Pubitemid 32592079)
34. Maguire, CA, Meijer, DH, LeRoy, SG, Tierney, LA, Broekman, ML, Costa, FF et al. (2008). Preventing growth of brain tumors by creating a zone of resistance. Mol Ther 16: 1695-1702.
35. Badr, CE, Wurdinger, T and Tannous, BA (2011). Functional drug screening assay reveals potential glioma therapeutics. Assay Drug Dev Technol 9: 281-289.
36. Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P et al. (2009). Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Neurosurgery 65: 610-624; discussion 624.
37. Cearley, CN, Vandenberghe, LH, Parente, MK, Carnish, ER, Wilson, JM and Wolfe, JH (2008). Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol Ther 16: 1710-1718.
38. Broekman, ML, Comer, LA, Hyman, BT and Sena-Esteves, M (2006). Adenoassociated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or-2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 138: 501-510. (Pubitemid 43255560)